期刊文献+

湖北地区宫颈癌组织HPV16 E7和E5转化基因变异分析 被引量:2

Polymorphisms of E7 and E5 Genes in Human Papillomavirus Type 16 Among Patients with Cervical Cancer in Hubei Province of China
原文传递
导出
摘要 目的:分析湖北地区宫颈癌组织HPV16E7和E5基因序列变异情况。方法:对87例宫颈鳞癌组织分别采用多重HPV16E7引物进行巢式PCR扩增和HPV16E5特异引物进行PCR扩增,并选择阳性扩增的基因片段DNA进行纯化、测序,检测基因变异。结果:测序成功的20例宫颈癌组织DNA中,HPV16E7基因的5个突变位点为:T846C、A647G、T732C、T789C、T795G,突变频率分别为85%(17/20)、70%(14/20)、15%(3/20),10%(2/20)、5%(1/20);HPV16E5基因的4个突变位点包括:A3979C、A4042G、G3868A、C3991T,突变频率分别为:80%(16/20)、90%(18/20)、5%(1/20)、5%(1/20)。结论:湖北地区宫颈癌的宫颈组织中HPV16E7热点突变为A647G和T846C,HPV16E5的热点突变为A3979C和A4042G,本研究为湖北地区宫颈癌流行病学的研究打下基础。 Objective:To identify the sequence variations in the HPV 16 E7 and E5 genes among patients with cervical cancer in Hubei province of China. Methods:Eighty-seven patients with cervical cancer were involved in this study. Using polymerase chain reaction (PCR) and PCR-directed sequencing methods,the variations of the HPV 16 E7 and E5 genes were investigated. Results:The rank orders of incidence of HPV16 E7 variants from cervical cancer in Hubei were as follows:T846C in 85% (17/20),A647G in 70% (14/20),T732C in 15% (3/20),T789C in 10% (2/20),and T795G in 5% (1/20). There are four points of mutation in E5 gene,including A3979C,A4042G,G3868A,and C3991T with mutant frequencies of 80%(16/20),90%(18/20),5%(1/20),and 5%(1/20),respectively. Conclusion:The hot-spot mutations of HPV16 from cervical cancer in Hubei are A647G and T846C in E7 gene,and A3979C and A4042G in HPV16 E5 gene. The characterization of sequence variations within high-risk HPV 16 might be important in the search for epidemiological cervical cancer risk factors.
出处 《武汉大学学报(医学版)》 CAS 北大核心 2009年第6期759-762,I0002,共5页 Medical Journal of Wuhan University
基金 湖北省卫生厅科研基金重点项目(编号:JX3A17)
关键词 宫颈癌 HPV16 E7和E5基因 基因多态性 Human Papillomavirusl6 (HPV16) Cervix Cancer E7 and E5 Genes~ Polymorphism
  • 相关文献

参考文献14

  • 1Cai HB, Ding XH, Chen CC. Prevalence of single and multiple human papillomavirus types in cervical cancer and precursor lesions in Hubei, China[J]. Oncology, 2009,76:157-161.
  • 2Eriksson A, Herron JR, Yamada T, et al. Human papillomavirus type 16 variant lineages characterized by nucleotide sequence analysis of the E5 coding segment and the E2 hinge region[J]. General Virology, 1999, 80:595-600.
  • 3Chan PK, Lam CW, Cheung TH, et al. Human papillomavirus type 16 intratypic variant infection and risk for eervieal neoplasia in southern China[J]. Infect Dis, 2002,186 :696-700.
  • 4Choi BS, Kim SS, Yun H, et al. Distinctive distribution of HPV16 E6 D25E and E7 N29S intratypic Asian variants in Korean commercial sex workers[J]. Med Virol, 2007, 79:426-430.
  • 5Pande S, Jain N, Prusty BK, et al. Human papillomavirus type 16 variant analysis of E6, ET, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India[J]. Clinical Microbiology, 2008,46:1 060-1 066.
  • 6Swan DC, Rajeevan M, Tortolero-Luna G, et al: Human papillomavirus type 16 E2 and E6/E7 variants[J] Gynecologic Ontology, 2005,96 : 695-700.
  • 7Nindl IK, Rindfleisch B, Lotz A, et al. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer[J]. Int J Cancer, 1999,82 : 203-207.
  • 8Hu XR, Pang TY, Guo ZM, et al. Oncogenel ineages of human papillomavirus typel6 E6, E7and E5 in prein- vasive and invasive cervical squamous cell carcinoma [J]. Pathol, 2001,195:307-311.
  • 9Tomesello ML, Duraturo ML, Salatiello I, et al. Analysis of Human Papillomavirus Type-16 Variants in Italian women with cervical intraepithelial neoplasia and cervical cancer[J]. Medical Virology, 2004,74 : 117-126.
  • 10Fujinaga Y, Okazawa K, Nishikawa A, et al. Sequence variation of human papillomavirus type 16 E7 in pre-invasive and invasive neoplasia[J]. Virus Genes, 1994,9: 85-92.

二级参考文献26

  • 1刘国炳,刘欣,庞战军,邢福祺,郭遂群,马文丽,张宝.宫颈癌组织中HPV16E6序列多态性及同源性分析[J].肿瘤防治杂志,2005,12(13):985-988. 被引量:4
  • 2杨英捷,赵健,李雪倩,廖秦平.2285例女性下生殖道人乳头状瘤病毒感染筛查结果分析[J].中国实用妇科与产科杂志,2006,22(6):444-445. 被引量:95
  • 3de Boer MA, Peters LA, Aziz MF, et al. Human papillomavirus type 16E6, E7, and LI variants in cervical cancer in Indonesia, Suriname, and The Netherlands. Gyneeol Oneol, 2004, 94(2) : 488-494.
  • 4Chang CH, Chen TH, Hsu RC, et al. The prevalence of HPV-18 and variants of E6 gene isolated from cervical cancer patients in Taiwan. J Clin Virol, 2005, 32 ( 1 ) : 33-37.
  • 5Ferenczy A, Franco E. Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol, 2002, 3 (1) : 11-16.
  • 6Watanabe S, Kanda T, Yoshiike K. Human papillomavirus type 16 transformation of primary human embryonic fibroblasts requires expression of open reading frames E6 and E7. J Virol, 1989, 63 (2) : 965-969.
  • 7Song YS, Kee SH, Kim JW, et al. Major sequence variants in E7 gene of human papillomavirus type 16 from cervical cancerous and noncancerous lesions of Korean women. Gynecol Oncol, 1997, 66(2) : 275-281.
  • 8Yamada T, Manos MM, Peto J, et al. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol, 1997, 71(3): 2463-2472.
  • 9Qiu AD, Wu EQ, Yu XH, et al. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China Gynecol Oncol, 2007, 104 (1): 77-85
  • 10Radhakrishna Pillai M, Sreevidya S, Pollock BH, et al. Human papillomavirus type 16 E6, E7 gene variations in Indian cervical cancer. Gynecol Oncol, 2002, 87(3):268-273.

共引文献15

同被引文献14

  • 1阎蓓,陈红,宋克玉,陈惠祯,吴绪峰,刘诗权,杨庆忆.SDZ PSC833和维拉帕米逆转宫颈癌耐药的对照研究[J].武汉大学学报(医学版),2007,28(4):431-433. 被引量:2
  • 2Busk M, Horsman MR, Kristjansen PE,et al. Aerobic glycolysis in cancers: implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia[J]. International journal of cancer, 2008,122(12): 2 726-2 734.
  • 3Morrissey C, True LD, Roudier MP,et al. Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases[J]. Clin Exp Metastasis, 2008, 25(4) : 377 388.
  • 4Wykosky J, Debinski W. The Eph A2 receptor and Ephrin A1 ligand in solid tumors: function and therapeutic targeting[J]. Mol Cancer Res, 2008, 6 (12):1 795-1 806.
  • 5Wykosky J, Palma E, Gibo DM, et al. Soluble monomeric Ephrin A1 is released from tumor cells and is a functional ligand for the EphA2 receptor[J]. Onco gene, 2008, 27(58):7 260-7 273.
  • 6Larsen AB, Stockhausen MT, Poulsen HS. Cell adhe sion and EGFR activation regulate Eph A2 expression in caneer[J]. Cell Signal, 2010, 22(4): 636-644.
  • 7Rekwirowicz H, Marszalek A. Hypoxia-inducible factor-1, a new possible important factor in neoplasia[J]. Pol J Pathol, 2009, 60 (2): 61-66.
  • 8Trollmann R, Schneider J,Keller S, et al. HIF1 regulated vasoactive systems are differentially involved in acute hypoxic stress responses of the developing brain of newborn mice and are not affected by levetiracetam[J]. Brain research, 2008, 1 199: 27-36.
  • 9Sasahara A, Kasuya H, Akagawa H, et al. Increased expression of ephrin A1 in brain arteriovenous malfor mation: DNA microarray analysis[J]. Neurosurg Rev, 2007,30(4) :99-305.
  • 10邓文霞,何莲芝.EphA2、VEGF、MVD在宫颈鳞癌组织中的表达及意义[J].皖南医学院学报,2009,28(2):96-99. 被引量:1

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部